MRI remains to be the backbone of measuring disease treatment and burden response in people with malignant gliomas. that try to more accurately determine disease response and status to treatment in malignant brain tumors. Practice Factors Contrast-enhanced MRI can be suboptimal for evaluation of disease burden and response to therapy in malignant gliomas since it… Continue reading MRI remains to be the backbone of measuring disease treatment and